Envista price target lowered to $18 from $20 at Stifel

Stifel analyst Jonathan Block lowered the firm’s price target on Envista to $18 from $20 and keeps a Buy rating on the shares. The firm’s Q2 dental checks suggest that general practitioner optimism or the providers’ outlook for the dental industry over the next 12 months has strengthened from prior quarters, says the analyst, who believes patient volume into the dental practice is “relatively solid,” but adds that conversion to higher-end restorative procedures is “more tepid.”